|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0025677,
umls-concept:C0030705,
umls-concept:C0033860,
umls-concept:C0205081,
umls-concept:C0205082,
umls-concept:C0205210,
umls-concept:C0439849,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-7-22
|
|
pubmed:abstractText |
CHAMPION was a phase III trial that compared adalimumab with methotrexate and placebo for chronic plaque psoriasis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1365-2133
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
165
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
399-406
|
|
pubmed:meshHeading |
pubmed-meshheading:21564071-Adult,
pubmed-meshheading:21564071-Aged,
pubmed-meshheading:21564071-Dermatologic Agents,
pubmed-meshheading:21564071-Dose-Response Relationship, Drug,
pubmed-meshheading:21564071-Female,
pubmed-meshheading:21564071-Humans,
pubmed-meshheading:21564071-Male,
pubmed-meshheading:21564071-Methotrexate,
pubmed-meshheading:21564071-Middle Aged,
pubmed-meshheading:21564071-Psoriasis,
pubmed-meshheading:21564071-Quality of Life,
pubmed-meshheading:21564071-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study.
|
|
pubmed:affiliation |
University Medical Center, Geneva, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
